Skip to main content
TipRanks
Go Ultimate75% OFF

ICU Medical (IC7) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

IC7 Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to ICU Medical in the past 3 months

IC7 Stock 12 Month Forecast

CHF164.00▲(0.00% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for ICU Medical in the last 3 months. The average price target is CHF 164.00 with a high forecast of CHF 167.06 and a low forecast of CHF 157.87. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF167.06Average Price TargetCHF164.00Lowest Price TargetCHF157.87

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:IC7
Price TargetArticle
KeyBancCHF156.20→CHF157.87buy―Reiterated11/06/26
Piper SandlerCHF162.88→CHF167.06buy―Reiterated11/06/26
BTIGCHF167.06buy―Reiterated11/05/26
NeedhamCHF137.82→CHF156.20buy―Assigned08/07/26
Raymond JamesCHF167.06buy―Reiterated08/07/26
JefferiesCHF146.18buy―Reiterated07/16/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ICU Medical

3 Months
Jason Bednar
Jason BednarPiper Sandler
Success Rate9/11 ratings generated profit
82%
Average Return
+10.17%

Copying Jason Bednar's trades and holding each position for 3 Months would result in 81.82% of your transactions generating a profit, with an average return of +10.17% per trade.

1 Year
Jason Bednar
Jason BednarPiper Sandler
Success Rate10/11 ratings generated profit
91%
Average Return
+24.36%

Copying Jason Bednar's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +24.36% per trade.

2 Years
Success Rate16/17 ratings generated profit
94%
Average Return
+24.12%

Copying Brett Fishbin's trades and holding each position for 2 Years would result in 94.12% of your transactions generating a profit, with an average return of +24.12% per trade.

IC7 Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for IC7
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy77765
Hold10000
Sell00000
Strong Sell00000
total87765

In the current month, IC7 has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IC7 average Analyst price target in the past 3 months is 164.00.

IC7 Financial Forecast

CHF0CHF0.75CHF1.5CHF2.25CHF3Q1 2026Q3 2026Q4 2026
HighCHF1.84
ConsensusCHF1.79
LowCHF1.76

IC7 Earnings Forecast

Next quarter’s earnings estimate for IC7 is CHF 1.79 with a range of CHF 1.76 to CHF 1.84. The previous quarter’s EPS was CHF 2.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF441.4MCHF448.9MCHF456.5MCHF464MCHF471.6MQ1 2026Q3 2026Q4 2026
HighCHF472M
ConsensusCHF465M
LowCHF462M

IC7 Sales Forecast

Next quarter’s sales forecast for IC7 is CHF 465.47M with a range of CHF 461.73M to CHF 471.55M. The previous quarter’s sales results were CHF 467.38M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

IC7 Stock Forecast FAQ

What is CH:IC7’s average 12-month price target, according to analysts?
Based on analyst ratings, ICU Medical’s 12-month average price target is CHF164.00.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ICU Medical a Buy, Sell or Hold?
ICU Medical has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is ICU Medical’s share price target?
The average share price target for ICU Medical is CHF164.00. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF167.06, and the lowest forecast is CHF157.87. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about ICU Medical?
ICU Medical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of ICU Medical?
To buy shares of CH:IC7, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.